» Articles » PMID: 16651631

Rapid Development of Salivary Gland Carcinomas Upon Conditional Expression of K-ras Driven by the Cytokeratin 5 Promoter

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2006 May 3
PMID 16651631
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We have used a recently described model in which a ras oncogene is expressed in cytokeratin 5 (K5)-expressing cells on doxycycline administration to explore the effects of this oncogene in salivary glands of adult mice. Inducible expression of a mutated K-ras gene under the control of the K5 promoter led to the development of hyperplastic and dysplastic epithelial lesions and carcinomas, with an incidence of 100% and a minimum latency of a week. All major salivary glands were affected, as well as a set of previously undescribed buccal accessory salivary glands located on the apex of the masseter muscle, close to the oral angle. The tumors appear to arise from the cytokeratin 5-positive basal cell compartment. Myoepithelial cells participated in the hyperplasias but not in carcinomas, because the tumors are negative for smooth muscle actin. Carcinomas did not accumulate immunoreactive p53 but are positive for p63, as assayed by immunohistochemistry using an antibody against the N terminus of DeltaN p63, a splice variant of p63 that can inhibit p53 transcriptional activity. In this study, we provide evidence that the ras oncogene, targeted to a specifically sensitive cell compartment within the salivary glands, can trigger a series of event that are sufficient for full carcinogenesis.

Citing Articles

A Mouse Model for Conditional Expression of Activated β-Catenin in Epidermal Keratinocytes.

Maurya V, Ying Y, Lydon J Transgenic Res. 2024; 33(5):513-525.

PMID: 39110314 PMC: 11588969. DOI: 10.1007/s11248-024-00402-z.


Salivary Gland Bioengineering.

Rose S, Larsen M, Xie Y, Sharfstein S Bioengineering (Basel). 2024; 11(1).

PMID: 38247905 PMC: 10813147. DOI: 10.3390/bioengineering11010028.


Histopathologic and transcriptomic phenotypes of a conditional RANKL transgenic mouse thymus.

Szwarc M, Hai L, Maurya V, Rajapakshe K, Perera D, Ittmann M Cytokine. 2022; 160:156022.

PMID: 36099756 PMC: 10255830. DOI: 10.1016/j.cyto.2022.156022.


Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice.

Schere-Levy C, Suberbordes M, Ferri D, Ayre M, Gattelli A, C Kordon E Int J Mol Sci. 2022; 23(7).

PMID: 35409002 PMC: 8998511. DOI: 10.3390/ijms23073642.


FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.

Isono Y, Furuya M, Kuwahara T, Sano D, Suzuki K, Jikuya R Biochem Biophys Res Commun. 2019; 522(4):931-938.

PMID: 31806376 PMC: 8195446. DOI: 10.1016/j.bbrc.2019.11.184.


References
1.
Jhappan C, Gallahan D, Stahle C, Chu E, Smith G, Merlino G . Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev. 1992; 6(3):345-55. DOI: 10.1101/gad.6.3.345. View

2.
Andres A, Schonenberger C, Groner B, Hennighausen L, Lemeur M, Gerlinger P . Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci U S A. 1987; 84(5):1299-303. PMC: 304415. DOI: 10.1073/pnas.84.5.1299. View

3.
Frank S, Nowak M . Cell biology: Developmental predisposition to cancer. Nature. 2003; 422(6931):494. DOI: 10.1038/422494a. View

4.
Schaffner D, Barrios R, Shaker M, Rajagopalan S, Huang S, Tindall D . Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms. Lab Invest. 1995; 72(3):283-90. View

5.
Stenman G, Sandros J, Mark J, Nordkvist A . High p21RAS expression levels correlate with chromosome 8 rearrangements in benign human mixed salivary gland tumors. Genes Chromosomes Cancer. 1989; 1(1):59-66. DOI: 10.1002/gcc.2870010110. View